6QZC image
Entry Detail
PDB ID:
6QZC
Keywords:
Title:
HLA-DR1 with the QAR Peptide
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2019-03-11
Release Date:
2020-07-15
Method Details:
Experimental Method:
Resolution:
1.64 Å
R-Value Free:
0.23
R-Value Work:
0.20
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:HLA class II histocompatibility antigen, DR alpha chain
Chain IDs:A (auth: AAA)
Chain Length:180
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:HLA class II histocompatibility antigen, DRB1-1 beta chain
Chain IDs:B (auth: BBB)
Chain Length:191
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:M1-208-222-QAR-Peptide
Chain IDs:C (auth: CCC)
Chain Length:16
Number of Molecules:1
Biological Source:Influenza A virus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSO B CYS modified residue
Primary Citation
CD4+T Cells Recognize Conserved Influenza A Epitopes through Shared Patterns of V-Gene Usage and Complementary Biochemical Features.
Cell Rep 32 107885 107885 (2020)
PMID: 32668259 DOI: 10.1016/j.celrep.2020.107885

Abstact

T cell recognition of peptides presented by human leukocyte antigens (HLAs) is mediated by the highly variable T cell receptor (TCR). Despite this built-in TCR variability, individuals can mount immune responses against viral epitopes by using identical or highly related TCRs expressed on CD8+ T cells. Characterization of these TCRs has extended our understanding of the molecular mechanisms that govern the recognition of peptide-HLA. However, few examples exist for CD4+ T cells. Here, we investigate CD4+ T cell responses to the internal proteins of the influenza A virus that correlate with protective immunity. We identify five internal epitopes that are commonly recognized by CD4+ T cells in five HLA-DR1+ subjects and show conservation across viral strains and zoonotic reservoirs. TCR repertoire analysis demonstrates several shared gene usage biases underpinned by complementary biochemical features evident in a structural comparison. These epitopes are attractive targets for vaccination and other T cell therapies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures